Artecan Artesunate 120 mg Injection – Product Description Artecan Artesunate 120 mg Injection contains Artesunate 120 mg, an injectable antimalarial medicine used primarily for the treatment of severe malaria. Artesunate is recommended by the World Health Organization as an effective parenteral treatment for severe malaria and has been shown to reduce mortality compared with parenteral quinine. Key Features Brand Name: Artecan Active Ingredient: Artesunate 120 mg Dosage Form: Powder for solution for injection Therapeutic Category: Antimalarial Primary Use: Treatment of severe malaria Route: Intravenous (IV) or intramuscular (IM), as directed by a qualified healthcare professional Pack Form: Typically supplied as a vial with appropriate diluent/solvent; exact pack contents should be verified from the manufacturer's label. WHO has prequalified a 120 mg artesunate powder-for-injection presentation for malaria treatment, demonstrating that the 120 mg strength is an established injectable formulation. Uses Artecan Artesunate 120 mg Injection may be used in hospital settings for severe malaria, particularly when rapid parenteral antimalarial treatment is required. Treatment should be followed by an appropriate complete antimalarial regimen according to clinical guidelines. Important Safety Information This injection should be prepared and administered only by trained healthcare professionals. The dose and treatment schedule depend on factors such as body weight and severity of malaria. Artesunate can rarely be associated with delayed haemolytic anaemia, so appropriate clinical monitoring may be required after treatment. Disclaimer: This product description is for informational and pharmaceutical listing purposes only. Artesunate injection is a prescription medicine and should be used strictly under medical supervision.